Praveen Advani, J&J Innovative Medicine
Praveen Advani, Commercial Insights & Strategy Lead – US Diabetes, J&J Innovative Medicine
Praveen Advani has more than 24 years of demonstrated leadership in US & Global pharmaceutical commercial excellence leading multiple cross functional teams to shape & influence strategic decisions. Praveen has been instrumental in successfully leading US & Global market research teams for several major global launches, most recently as the Executive Director for WW Immuno-Oncology at Bristol Myers Squibb where he was responsible for leading all the US and International market research efforts to help successfully launch one of the fastest growing brands in the industry – Opdivo. Prior to that, he has successfully led the market research efforts for Januvia/Janumet (Diabetes, Merck) and Lantus (Diabetes, Aventis/Sanofi)
Praveen holds a MBA from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering from the University of Pune, India.
Arvind Balasundaram, Regeneron
Arvind Balasundaram, Executive Director, Commercial Insights & Analytics, Regeneron
Arvind leads the Commercial Insights & Analytics (I&A) group at Regeneron, a leading biotechnology company that invents life-transforming medicines for people with serious diseases. In this capacity, he oversees the implementation of deep insight frameworks and analytical capabilities to help bring the power of science and new medicines to patients who need them. A primary focus of the I&A group is to help realize Regeneron’s mission to do well by doing good.
Prior to Regeneron, Arvind also spent time at Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer, mostly on the early pipeline and launch side of the business. During his tenure at these companies, he participated in a number of industry-leading pharma brand launches, spanning several therapeutic areas.
Arvind earned his MBA from the Owen Graduate School of Management at Vanderbilt University. He also recently attained the Award of Achievement in Digital Analytics degree from the University of British Columbia (in association with the Digital Analytics Association) as well as a Certification in Data Science at UC, Irvine (in association with Predictive Analytics World). He is a former Associate in the Applied Analytics Capstone program at Columbia University, and a member of the Design Thinking Advisory Board at Rutgers University.
Arvind is a past President of the Pharmaceutical Management Science Association (PMSA). His interests include exploring new capabilities to enrich understanding of customer experience and engagement in multichannel business ecosystems, staying engaged in the evolution of machine intelligence and the Analytics of Things, as well as identifying choice contexts and biases in noisy decision-making environments.
Lisa Courtade, Organon & Co., LLC
Lisa Courtade, Associate Vice President, Global Business Insights & Analytics, Organon & Co., LLC
Lisa has been called an “innovative disrupter” and a “change agent” for challenging the status quo and harnessing emerging technologies and data to identify deep insights and new market opportunities. She joined Organon for the opportunity to build a new team with the power to leverage the full suite of insights capabilities to understand and deliver on the unmet needs in women’s health. Creating a boundaryless organization with skills in analytics and decision science, forecasting, pricing, marketing research, foresight, social analytics, experience design and competitive intelligence, the team is dedicated to creating innovative, compliant solutions to the challenges facing patients, providers, and payers in the delivery of lifesaving and life enhancing medicines and devices. As Past-Chair of the Insights Association, past-President of the MRII, and advisor to many educational institutions and associations in the insights and analytics profession, Lisa is dedicated to advancing the education, leadership, and agility of current and future talent in the industry.
Stuart Greenberg, Sun Pharma
Stuart Greenberg, Director, Market Insights & Analytics, Sun Pharma
Dr. Stuart E. Greenberg is currently Director, Market Insights & Analytics, Sun Pharmaceutical Industries. In the past he has been on the Global Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
Ken Kirsch, Aveo Oncology an LG Chem Company
Ken Kirsch, Director, Market Insights, Aveo Oncology an LG Chem Company
Ken Kirsch is a tenured and broadly skilled pharmaceutical market insights professional with experience in oncology, rare disease and retail markets. Ken started his career as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin. Ken then moved to the manufacturer side of the industry, where he has led US and Global market insights for oncology, rare disease, and retail therapies at Wyeth, GSK and AstraZeneca. At Wyeth and GSK, Ken led US and Global insights on several oncology launches across tumor types and specialties.
Ken is currently the Director of Market Insights for Aveo Oncology, where he is the functional lead for both market insights and competitive intelligence.
Ken holds an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University in Philadelphia. He also sits on the Advisory Board of the Pharmaceutical Market Research Conference. Ken lives in Collegeville, PA with his wife Patty. Their daughters Hannah and Elizabeth attend the University of Pittsburgh and University of Delaware, respectively. In his spare time, Ken enjoys playing with his two English Springer Spaniels, Ollie and Finley, and volunteering (but not performing) with Methacton Community Theater.
Richard McCloud, Pfizer
Richard McCloud, Director, Business Analytics and Insights, Pfizer
Rich McCloud is a Director, Business Analytics and Insights, supporting the Pediatric Vaccines Business.
Rich has over 20 years of consulting experience, providing decision support across multiple therapeutic areas, and high priority brands such as Celebrex, Lyrica, Cymbalta, Xolair, biosimilars, and tanezumab. His experience includes a strong history in launching prime mover products and preparing for new competitors.
Rich started his career in pharmaceutical consulting at ZS Associates and moved to Pfizer in 2001. His first position was on Celebrex, where he was responsible for supporting the HCP launch. He launched the Lyrica fibromyalgia indication before moving to Genentech, where he gained biologics and medical benefit reimbursement experience working on Xolair. He also has DTC experience from working on the very successful Cymbalta DTC campaigns in both chronic pain and depression indications.
Rich returned to New York and Pfizer in 2009 to work on Lyrica. He moved to the Biosimilars team in 2013, and supported global launch of Inflectra, and three Oncology Biosimilar assets for Herceptin, Rituxan, and Avastin. Most recently, Rich worked on Tanezumab where he led groundbreaking initiatives on performance measurement, scenario planning for new competitors, and finding new opportunities within patient journey.
Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree from the University of Georgia. In his (spare?) time, Rich and Tanya continually chase, encourage, and celebrate their four children (Gabrielle (15), Hendrix (11), Lillian (10), and Maxwell (5).
Jit Mitra, Merck
Jit Mitra, Associate Director, Market Research & Analytics, Rare Diseases, Chronic Care and Neuroscience, Merck
Jit has over 20 years’ experience in supporting insights for pharmaceutical products. A strategist at heart who fully understands the role of critical thinking and intellectual curiosity in developing commercial strategy in support of both in-line and launch brands, globally. Jit has been involved in leading the insights to support three major global drug launches in the past 5 years – Sotatercept (PAH), Lyfnua (Chronic Cough) and Ajovy (Migraine). In his current role, Jit collaborates closely with the global brand team leads and other key stakeholders (market access, patient experience, medical) in the support of the accelerated global launch of Sotatercept – studied in patients with pulmonary arterial hypertension (PAH). Jit has been a presenter/panellist at numerous industry meetings including: PMSA, PMRC, PMRG/PBRG. Jit has earned his Bachelor of Commerce from St. Xavier’s College in Calcutta, India and his MBA from Rochester Institute of Technology.
Andrea Mulford, EMD Serono, Inc.
Andrea Mulford, VP of Global Strategic Insights, EMD Serono, Inc.
Grace Samoil Reynolds, Immunovant
Grace Samoil Reynolds, Head of Market Insights & Analytics, Immunovant
Grace is Head of Market Insights & Analytics at Immunovant. She was previously Senior Director Customer Insight Immunology at Bristol-Myers Squibb, and before that was at Johnson & Johnson where she joined in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her passion is driving innovation and future thinking.